Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study

被引：0
|
作者：
Mao, R. [1 ]
He, Y. [1 ]
Ben-Horin, S. [2 ]
Chen, M. -H. [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Sheba Med Ctr, Tel Aviv, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P441
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [1] Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
    He, Yao
    Mao, Ren
    Chen, Fang
    Xu, Ping-Ping
    Chen, Bai-Li
    Wu, Yun
    Qiu, Yun
    Zhang, Sheng-Hong
    Feng, Rui
    Zeng, Zhi-Rong
    Ben-Horin, Shomron
    Chen, Min-Hu
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (05) : 397 - 406
  • [2] Thalidomide Induces Mucosal Healing in Crohn's Disease
    Lazzerini, M.
    Maschio, M.
    Martelossi, S.
    Di Leo, D.
    Ventura, A.
    WCPGHAN 3: WORLD CONGRESS OF PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION, 2008, : 13 - +
  • [3] MUCOSAL HEALING AND CLINICAL REMISSION AFTER TREATMENT WITH ADALIMUMAB IN SMALL INTESTINAL CROHN'S DISEASE (SIMCHA STUDY): FINAL RESULTS FROM A PROSPECTIVE, OPEN-LABEL, SINGLEARM STUDY
    Wetwittayakhlang, Panu
    Golovics, Petra A.
    Hahn, Gustavo
    Bessissow, Talat
    Bitton, Alain
    Afif, Waqqas
    Wild, Gary
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2022, 162 (07) : S823 - S823
  • [4] Thalidomide induces mucosal healing in Crohn's disease: Case report
    Márcio Rios Leite
    Sandra Sousa Santos
    André Castro Lyra
    Jaciane Mota
    Genoile Oliveira Santana
    World Journal of Gastroenterology, 2011, 17 (45) : 5028 - 5031
  • [5] Thalidomide induces mucosal healing in Crohn's disease: Case report
    Leite, Marcio Rios
    Santos, Sandra Sousa
    Lyra, Andre Castro
    Mota, Jaciane
    Santana, Genoile Oliveira
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (45) : 5028 - 5031
  • [6] Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
    Wetwittayakhlang, P.
    Golovics, P.
    Hahn, G.
    Bessissow, T.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I343 - I344
  • [7] Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
    Wetwittayakhlang, P.
    Golovics, P.
    Hahn, G.
    Bessissow, T.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I343 - I344
  • [8] An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
    Sabate, JM
    Villarejo, J
    Lemann, M
    Bonnet, J
    Allez, M
    Modigliani, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1117 - 1124
  • [9] An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
    Sabate, JM
    Villarejo, J
    Lemann, M
    Bonnet, J
    Allez, M
    Modigliani, R
    GASTROENTEROLOGY, 2002, 122 (04) : A498 - A498
  • [10] Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
    Ehrenpreis, ED
    Kane, SV
    Cohen, LB
    Cohen, RD
    Hanauer, SB
    GASTROENTEROLOGY, 1999, 117 (06) : 1271 - 1277
12345